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http://dx.doi.org/10.1016/j.jmii.2015
1684-1182/Copyright ª 2015, TaiwanAbstract Background/Purpose: Patients admitted to intensive care units (ICUs) are at high
risk for central line-associated bloodstream infections (CLABSIs). Bundle care has been docu-
mented to reduce CLABSI rates in Western countries, however, few reports were from Asian
countries and the differences in the epidemiology or outcomes of critically-ill patients with
CLABSIs after implementation of bundle care remain unknown. We aimed to evaluate the inci-
dence, microbiological characteristics, and factors associated with mortality in critically-ill
patients after implementation of bundle care.
Methods: Prospective surveillance was performed on patients admitted to ICUs at the National
Taiwan University Hospital, Taipei, Taiwan from January 2012 to June 2013. The demographic,
microbiological, and clinical data of patients who developed CLABSI according to the National
Healthcare Safety Network definition were reviewed. A total of 181 episodes of CLABSI were
assessed in 156 patients over 46,020 central-catheter days.of Internal Medicine, National Taiwan University Hospital, Number 7, Chung-Shan South Road, Taipei,
.tw (W.-H. Sheng).
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bundle care, Journal of MicrobiologyResults: The incidence of CLABSI was 3.93 per 1000 central-catheter days. The predominant
causative microorganisms isolated from CLABSI episodes were Gram-negative bacteria
(39.2%), followed by Gram-positive bacteria (33.2%) and Candida spp. (27.6%). Median time
from insertion of a central catheter to occurrence of CLABSI was 8 days. In multivariate anal-
ysis, the independent factors associated with mortality were higher Pitt bacteremia score
[odds ratio (OR) 1.41; 95% confidence interval (CI) 1.18e1.68] and longer interval between
onset of CLABSIs and catheter removal (OR 1.10; 95% CI 1.02e1.20), respectively.
Conclusion: In institutions with a high proportion of CLABSI caused by Gram-negative bacteria,
severity of bacteremia and delay in catheter removal were significant factors associated with
mortality.
Copyright ª 2015, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Central lines are widely used in critically-ill patients. Since
central lines are increasingly prevalent, it is important to
note that central line-associated bloodstream infection
(CLABSI) is a leading cause of preventable health care-
associated infections (HAIs) and that catheter-related
bloodstream infections (CRBSI) have resulted in longer
hospital stays, higher hospital costs, and significant mor-
tality.1e3 Fortunately, surveillance of CLABSIs followed by
implementation of improvement strategies can reduce
CLABSI incidence and associated morbidity and mortality.3,4
After incorporating preventive measures into an inter-
ventional bundle, the authors of a 2006 study observed a
decrease in CLABSI rate.5 Following this observation,
several studies conducted in Western industrialized coun-
tries proposed that achieving and maintaining a rate of zero
CLABSI was possible with the implementation of preventive
measures,6e8 however, CLABSIs remain a major component
of HAIs in developing countries, where the target of zero
CLABSI was reached in only a few studies.7,9 CLABSIs are
observed more frequently in intensive care units (ICUs).
The high rates of CLABSI in ICUs have been attributed to
poor compliance with the interventional bundle, inappro-
priate development of additional preventive measures, and
differences in microbiological epidemiology.7 The causative
microorganisms of CLABSIs reported from the developing
countries were predominantly Gram-negative bacteria,
with trends of increasing incidence in recent years.10e13
With the aforementioned preventive measures, reduction
in CLABSIs caused by Staphylococcus aureus was more sig-
nificant than CLABSIs caused by Gram-negative bacteria
and Candida spp.14 Further analysis of microbiological data
should enable further development of pathogen-specific
preventive measures.
Although there have been many international CLABSI
studies, few have focused on the clinical characteristics of
CLABSIs in Asian countries.7,15,16 In the 2011 report from the
Taiwan Nosocomial Infections Surveillance System (TNIS),
bloodstream infections topped the list of HAIs (39.8%) in
ICUs in Taiwan. In this study, we aimed to evaluate the
epidemiology, microbiological data, and risk factors asso-
ciated with mortality from CLABSI among patients admitted
to an ICU in a tertiary medical center.K-Y, et al., Central line-associate
, Immunology and Infection (2015Methods
Hospital setting and patient population
The National Taiwan University Hospital, Taipei, Taiwan is a
large medical center that provides both primary and ter-
tiary care. A CLABSI interventional bundle has been
implemented according to the recommendations of Centers
for Disease Control and Prevention (CDC) guidelines in all
units of our hospital since 2011. The elements of the care
bundle included hand hygiene, maximal barrier pre-
cautions, skin antisepsis with 2% chlorhexidine alcohol
(Panion & BF Biotech, Inc., Taipei, Taiwan), optimal cath-
eter site selection, catheter-site dressing regimens, and
daily evaluation and removal of unnecessary catheters.4
The daily mean of catheter-days was defined as the mean
of daily number of total central-catheter days, and cath-
eter utilization rate was calculated by dividing the number
of catheter days by the number of patient days.17,18 In 2011
before the implementation of bundle care, the rate of
CLABSI was 7.40 per 1000 central-catheter days, with a
daily mean of 89.0 catheter-days and a catheter utilization
rate of 64.4% in ICUs.
In this study, a total of 150 adult ICU beds (44 medical
ICU beds, 39 cardiac care unit beds, 12 neurologic ICU
beds, and 55 surgical ICU beds) were included in the high-
risk units under surveillance. The ratio of nurses to ICU
patients was 1:2. Prospective active surveillance was
performed by infection-control nurses in all adult pa-
tients admitted to ICUs between January 2012 and June
2013. Antimicrobial impregnated catheters were not
routinely used unless patients developed recurrent
bacteremia or were at high risk for catheter-related
bloodstream infections, including those with higher
Charlson comorbidity indices and nosocomial origins of
infection.19
During the study period, all patients aged  18 years and
having one or more central-line catheterization were
enrolled in this study. We monitored CLABSI episodes from
central-line insertion until catheter removal, discharge
from the ICU, or death. Given that a patient could develop
more than one CLABSI episode, a new episode was defined
by the isolation of a different microorganism from subse-
quent blood cultures.20d bloodstream infections among critically-ill patients in the era of
), http://dx.doi.org/10.1016/j.jmii.2015.07.001
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CLABSI was defined according to the surveillance definition
published by the National Healthcare Safety Network
(NHSN) in 2008.21 Briefly, at least one of the following
criteria must be met in the absence of a site-specific
infection and the presence of a central vascular catheter:
(1) a recognized pathogen is cultured from one or more
blood cultures or (2) the same common commensal is
cultured from two or more blood cultures drawn on sepa-
rate occasions in the presence of signs and symptoms of
infection. In contrast with the definition for CLABSI used for
surveillance purposes, we used CRBSI for clinical diagnosis
and treatment. A definitive diagnosis of CRBSI was made
when the conditions for CLABSI were met in conjunction
with positive semi-quantitative tip cultures (> 15 colony-
forming units per catheter tip segment) or by a differential
time-to-positivity of > 2 hours in simultaneous blood cul-
tures drawn from peripheral blood and via catheters.22
The definitions of the underlying diseases were applied
according to the comorbid conditions of the Charlson co-
morbidity index.23 In brief, the cardiovascular diseases
included myocardial infarction, congestive heart failure,
and peripheral vascular disease. The neurological diseases
included cerebrovascular disease, dementia, and hemiple-
gia. The respiratory diseases included chronic pulmonary
diseases (such as chronic obstructive pulmonary disease,
chronic asthma, and pneumoconiosis). The hepatobiliary
disease was defined as chronic hepatitis (such as chronic
viral hepatitis with persistent or intermittent elevation in
serum aminotransferase for  6 months) with or without
portal hypertension. The renal diseases included end-stage
renal disease and moderate-to-severe renal disease with
reduced glomerular filtration rate or kidney damage (<
60 mL/min/1.73 m2 of body-surface area) for > 3 months.
The immunosuppressive status referred to patients with
acquired immunodeficiency syndrome. Multidrug-resistance
was defined by in vitro resistance to three different classes
of antimicrobial agents. For example, multidrug-resistant
Acinetobacter baumannii was defined as if A. baumannii
was resistant to three or more of the following five anti-
biotic classes: aminoglycosides, ampicillin/sulbactam,
antipseudomonal carbapenems, antipseudomonal cephalo-
sporins, and fluoroquinolones. Bacteremia eradication was
documented.Data collection
We used a standardized case-record form to collect infor-
mation from every CLABSI episode. Infection control prac-
titioners performed active surveillance and recorded the
general information, which included baseline de-
mographics, length of ICU stay and hospitalization, type of
ICU, type of catheter, and causative pathogen. An
infectious-disease specialist excluded all secondary blood-
stream infections by assessing the possibility of other site-
specific infections. By reviewing the medical records of
those patients with CLABSIs, we recorded their underlying
diseases, diagnosis on ICU admission, clinical signs and
laboratory data, characteristics of the catheter, antimi-
crobial therapy, catheter removal, and 14-day hospitalPlease cite this article in press as: Lin K-Y, et al., Central line-associate
bundle care, Journal of Microbiology, Immunology and Infection (2015mortality. Antimicrobial therapy was considered adequate
when the antimicrobial regimen included any active anti-
microbial agent to which the pathogen was susceptible by
in vitro susceptibility testing results administered during
this episode of infection. The study was approved by the
Research Ethics Committee of the National Taiwan Uni-
versity Hospital (NTUH-201102049RC).
Statistical analysis
The incidence of CLABSIs and CRBSIs was expressed as ep-
isodes per 1000 central-catheter days, and a Poisson dis-
tribution was used to compare the incidence of CLABSI at
baseline and during the study period. Categorical variables
were compared with a Chi-square test or Fisher’s exact test
if the expected values were < 10. Continuous variables
were described as mean  standard deviation (SD) and
were compared using the Student t test, or were described
as the median and range, and were compared with the
Wilcoxon rank-sum test if their distributions were not
normal. Factors associated with acquiring CLABSI or CRBSI
and mortality were identified using multivariate logistic
regression models, with variables entered into the model
with a backward stepwise logistic regression approach with
p < 0.2 as a requirement for acceptance. Ninety-five
percent confidence intervals (CIs) of odds ratios (ORs)
were computed. All tests were two-tailed and p < 0.05 was
considered statistically significant. Statistical analyses
were performed using SPSS software version 17.0 (SPSS Inc.,
Chicago, IL, USA).
Results
From January 2012 to June 2013, a total of 156 patients
with 181 episodes of CLABSIs were identified among 46,020
central-catheter days of surveillance. The mean rate of
CLABSI was 3.93 per 1000 central-catheter days, with a
daily mean of 84.0 catheter-days and a catheter utilization
rate of 61.1%. The rate of CLABSI decreased from 7.40 per
1000 central-catheter days at baseline (before imple-
mentation of CLABSI bundle) to 3.93 per 1000 central-
catheter days after intervention (p > 0.05). Among the 181
episodes of CLABSIs, 31 episodes fulfilled the definition of
CRBSI, with the mean rate of CRBSI at 0.67 per 1000
central-catheter days. The demographics and clinical
characteristics of all patients with CLABSI, those with
CLABSI not meeting criteria for CRBSIs, and those with
CRBSI are summarized in Table 1.
Of the patients with CLABSIs, 113 (62.4%) were male
with a mean age of 66.3 years. The major underlying dis-
ease was malignancy (42.5%), followed by cardiovascular
disease (39.2%) and diabetes mellitus (35.4%). Patients
were admitted to ICUs mostly for sepsis (55.8%), followed
by respiratory disease (42.0%) and cardiovascular disease
(17.1%). Less than half of the patients received total
parenteral nutrition (TPN) and anti-fungal agents, and the
average number of antibiotics used prior to CLABSI was
three (it is not easy to be exposed to 0.1e0.9 antibiotics).
On average, each patient underwent placement of 1.6
central lines, most of which had triple lumens (86.7%) and
were placed in the internal jugular veins (59.7%) in an ICUd bloodstream infections among critically-ill patients in the era of
), http://dx.doi.org/10.1016/j.jmii.2015.07.001
Table 1 Demographics and clinical characteristics of patients with CLABSIs and CRBSIs
Variable CLABSI p
Overall (n Z 181) CLABSI (CRBSI excluded; n Z 150) CRBSI (n Z 31)
Age (y) 66.3  15.8 65.4  15.8 70.6  15.6 0.036
Male 113 (62.4) 96 (64.0) 17 (54.8) 0.338
Underlying disease
Cardiovascular disease 71 (39.2) 55 (36.7) 16 (51.6) 0.121
Neurological disease 48 (26.5) 42 (28.0) 6 (19.4) 0.321
Respiratory disease 28 (15.5) 25 (16.7) 3 (9.7) 0.327
Gastrointestinal disease 25 (13.8) 19 (12.7) 6 (19.4) 0.326
Hepatobiliary disease 38 (21.0) 31 (20.7) 7 (22.6) 0.812
Renal disease 59 (32.6) 47 (31.3) 12 (38.7) 0.425
Autoimmune disease 12 (6.6) 10 (6.7) 2 (6.5) 0.965
Diabetes mellitus 64 (35.4) 51 (34.0) 13 (41.9) 0.400
Malignancy 77 (42.5) 65 (43.3) 12 (38.7) 0.635
Immunosuppression 10 (5.5) 9 (6.0) 1 (3.2) 0.538
Charlson comorbidity index 4.6  2.8 4.6  2.8 4.5  2.8 0.983
Major diagnosis on ICU admission
Cardiovascular disease 31 (17.1) 24 (16.0) 7 (22.6) 0.376
Neurological disease 8 (4.4) 7 (4.7) 1 (3.2) 0.722
Respiratory disease 76 (42.0) 63 (42.0) 13 (41.9) 0.995
Gastrointestinal disease 16 (8.8) 15 (10.0) 1 (3.2) 0.226
Hepatobiliary disease 6 (3.3) 6 (4.0) 0 (0) 0.257
Genitourinary disease 10 (5.5) 8 (5.3) 2 (6.5) 0.804
Malignancy 9 (5.0) 7 (4.7) 2 (6.5) 0.677
Sepsis 101 (55.8) 85 (56.7) 16 (51.6) 0.606
Trauma 6 (3.3) 3 (2.0) 3 (9.7) 0.064
APACHE II score 21.7  8.5 22.2  8.4 19.4  8.3 0.115
Receipt of TPN 29 (16.0) 21 (14.0) 8 (25.8) 0.103
Previous use of antibiotics 3.0  1.9 3.1  1.8 2.6  2.2 0.061
Previous use of anti-fungal agent 68 (37.6) 58 (38.7) 10 (32.3) 0.502
Number of catheter 1.6  0.6 1.6  0.6 1.7  0.6 0.496
Catheter lumen
Single lumen 5 (2.8) 3 (2.0) 2 (6.5) 0.169
Dual lumen 19 (10.5) 15 (10.0) 4 (12.9) 0.631
Triple lumen 157 (86.7) 132 (88.0) 25 (80.7) 0.272
Anatomic site
Internal jugular vein 108 (59.7) 95 (63.3) 13 (41.9) 0.027
Subclavian vein 29 (16.0) 21 (14.0) 8 (25.8) 0.103
Femoral vein 46 (25.4) 34 (22.7) 12 (38.7) 0.062
Place of line insertion 0.692
ICU 117 (64.6) 96 (64.0) 21 (67.7)
Non-ICU 64 (35.4) 54 (36.0) 10 (32.3)
Interval from ICU admission to onset
of catheter infection (d)
12.0 (3e97) 11.0 (3e97) 18 (4e53) 0.019
Interval from catheter placement to
onset of catheter infection (d)
8.0 (2e778) 8.0 (2e778) 13.0 (4e154) <0.001
14-day mortality 70 (38.7) 62 (41.3) 8 (25.8) 0.106
Data are presented as n (%), mean  SD, or median (range).
APACHEZ acute physiology and chronic health evaluation; CLABSIZ central line-associated bloodstream infection; CRBSIZ catheter-
related bloodstream infection; ICU Z intensive care unit; TPN Z total parenteral nutrition.
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+ MODELsetting (64.6%). The median duration from ICU admission
and placement of central lines to occurrence of CLABSIs
was 12.0 days and 8.0 days, respectively. Patients with
CRBSIs were older than patients with CLABSIs (70.6 years vs.
65.4 years, p Z 0.036) and had a lower proportion of
catheter placement in the jugular vein (41.9% vs. 63.3%,
p Z 0.027), longer ICU stay (18.0 days vs. 11.0 days,Please cite this article in press as: Lin K-Y, et al., Central line-associate
bundle care, Journal of Microbiology, Immunology and Infection (2015p Z 0.019), and longer duration of catheterization (13.0
days vs. 8.0 days, p < 0.001; Table 1).
The etiological agents associated with CLABSIs and
CRBSIs are listed in Table 2. The most common pathogens
causing CLABSI following bundle care were Gram-negative
bacteria (38.0%), followed by Gram-positive bacteria
(34.7%), Candida spp. (24.0%), and anaerobes (4.7%).d bloodstream infections among critically-ill patients in the era of
), http://dx.doi.org/10.1016/j.jmii.2015.07.001
Table 2 Causative microorganisms responsible for CLABSIs
Microorganism CLABSI
Overall (n Z 181) CLABSI (CRBSI excluded; n Z 150) CRBSI (n Z 31) p
Gram-positive bacteria 60 (33.2) 52 (34.7) 8 (25.8) 0.340
Enterococcus spp. 39 (21.6) 35 (23.3) 4 (12.9)
Coagulase-negative staphylococci 17 (9.4) 16 (10.7) 1 (3.2)
Staphylococcus aureus 6 (3.3) 3 (2.0) 3 (9.7)
Gram-negative bacteria 71 (39.2) 57 (38.0) 14 (45.2) 0.457
Enterobacteriaceae 26 (14.4) 18 (12.0) 8 (25.8)
Citrobacter spp. 2 (1.1) 2 (1.3) 0 (0)
Enterobacter spp. 6 (3.3) 4 (2.7) 2 (6.5)
Escherichia coli 6 (3.3) 6 (4.0) 0 (0)
Klebsiella spp. 4 (2.2) 2 (1.3) 2 (6.5)
Proteus spp. 3 (1.7) 0 (0) 3 (9.7)
Serratia marcescens 5 (2.8) 4 (2.7) 1 (3.2)
NFGNB 49 (27.1) 36 (24.0) 10 (32.3)
Acinetobacter spp. 12 (6.6) 10 (6.7) 2 (6.5)
Achromobacter spp. 2 (1.1) 2 (1.3) 0 (0)
Burkholderia cepacia 10 (5.5) 8 (5.3) 2 (6.5)
Chryseobacterium spp. 10 (5.5) 8 (5.3) 2 (6.5)
Pseudomonas spp. 7 (3.9) 3 (2.0) 4 (12.9)
Stenotrophomonas maltophilia 4 (2.2) 3 (2.0) 1 (3.2)
Othersa 5 (2.8) 5 (3.3) 0 (0)
Anaerobes 8 (4.4) 8 (5.3) 0 (0) 0.220
Bacteroides spp. 7 (3.9) 7 (4.7) 0 (0)
Prevotella spp. 1 (0.6) 1 (0.7) 0 (0)
Fungi 50 (27.6) 37 (24.7) 13 (41.9) 0.050
Candida albicans 21 (11.6) 18 (12.0) 3 (9.7)
Candida glabrata 8 (4.4) 6 (4.0) 2 (6.5)
Candida krusei 3 (1.7) 1 (0.7) 2 (6.5)
Candida parapsilosis 3 (1.7) 3 (2.0) 0 (0)
Candida tropicalis 12 (6.6) 7 (4.7) 5 (16.1)
Othersb 3 (1.7) 2 (1.3) 1 (3.2)
Resistant strainc 47 (26.0) 39 (26.0) 8 (25.8) 0.982
Polymicrobial infectionsd 14 (7.7) 8 (5.3) 6 (19.4) 0.017
Data are presented as n (%).
CLABSIZ central line-associated bloodstream infection; CRBSIZ catheter-related bloodstream infection; NFGNB Z non-fermentative
gram-negative bacilli.
a Other NFGNB included two Delftia spp. (1.1%), one Ralstonia spp. (0.6%), and two Sphingomonas paucimobilis (1.1%).
b Other fungi included one Candida guilliermondii (0.6%), one unidentified Candida species (0.6%), and one Saccharomyces cerevisiae
(0.6%).
c Resistant strains included carbapenem-resistant Enterobacteriaceae, methicillin-resistant Staphylococcus aureus, methicillin-
resistant coagulase-negative staphylococci, multidrug-resistant Acinetobacter baumannii, and vancomycin resistant Enterococcus.
d The 14 polymicrobial infections mostly included Candida spp. (n Z 4), followed by Chryseobacterium spp. (n Z 3), Pseudomonas
aeruginosa (n Z 3), Stenotrophomonas maltophilia (n Z 3), and Acinetobacter spp. (n Z 2).
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CLABSI, the most common pathogens associated with
CRBSIs were Gram-negative bacteria (45.2%), followed by
Candida spp. (41.9%) and Gram-positive bacteria (25.8%). In
both the CLABSI and CRBSI groups, the most common
causative Gram-positive bacteria, Gram-negative bacteria,
and fungi were Enterococcus spp., nonfermentative Gram-
negative bacilli (NFGNB), and Candida spp. Among cath-
eter infections, 26.0% of causative organisms were resistant
strains. Compared with patients with CLABSIs, patients with
CRBSIs had a higher percentage of Candida infections
(41.9% vs. 24.7%, p Z 0.050) and polymicrobial infections
(19.4% vs. 5.3%, p Z 0.017). Comparing the risk factors ofPlease cite this article in press as: Lin K-Y, et al., Central line-associate
bundle care, Journal of Microbiology, Immunology and Infection (2015acquiring Gram-positive versus Gram-negative bacteria,
more patients with Gram-positive associated CLABSIs had
chronic pulmonary disease (34.0% vs. 8.2%, p Z 0.001) and
received TPN (20.8% vs. 6.6%, p Z 0.025). Gram-negative-
bacteria-related CLABSIs significantly increased when the
ICU stay lasted beyond 14 days (p Z 0.019) (Figure 1).
The 14-day mortality of CLABSIs and CRBSIs was 38.7%
and 25.8%, respectively. Factors associated with 14-day
mortality in CLABSIs are shown in Table 3. By univariate
analysis, patients with neurologic disease, catheter
removal, and eradication of bacteremia (may need to
define when repeat blood cultures to document eradication
were taken, whether all had repeat blood cultures done,d bloodstream infections among critically-ill patients in the era of
), http://dx.doi.org/10.1016/j.jmii.2015.07.001
Figure 1. Microbiologic distribution associated with duration
of ICU stay  14 days and > 14 days. ICU Z intensive care
units.
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beyond 14 days (all p < 0.05). By contrast, patients with
catheter placement in the ICU setting and higher Pitt
bacteremia scores with manifestations of shock and
disseminated intravascular coagulopathy were more likely
to die within 14 days (all p < 0.05). By multivariate anal-
ysis, increased Pitt bacteremia scores and intervals be-
tween onset of CLABSIs and catheter removal were
independently associated with 14-day mortality risk (OR
1.41, 95% CI 1.18e1.68; OR 1.10, 95% CI 1.02e1.20,
respectively), however, the underlying disease, diagnosis
on admission, causative pathogen, setting of catheter
insertion, anatomic site of catheter, and adequate or
combined antimicrobial therapy were not associated with
mortality. There was also no difference between the 14-day
mortality rate of CLABSI caused by Gram-positive and that
of CLABSI caused by Gram-negative bacteria (37.7% vs.
32.8%, p Z 0.581). Of those patients with Gram-positive-
bacteria-related CLABSIs, multivariate analysis showed
that cardiovascular disease and higher Pitt bacteremia
score (OR 3.83, 95% CI 1.06e13.87; OR 1.30; 95% CI
1.01e1.68, respectively) were the factors associated with
14-day mortality. Of those patients with Gram-negative-
bacteria-related CLABSIs, only higher Pitt bacteremia
score (OR 1.37, 95% CI 1.07e15.87) was the independent
factor predicting 14-day mortality.Discussion
To the best of our knowledge, there have been few sur-
veillance studies of CLABSI from Asian countries after the
NHSN first published the definition in 2008.7,15,16 The pre-
sent study aimed to evaluate the incidence, etiology, and
factors associated with mortality of CLABSI in Asian adult
ICUs. After implementation of CLABSI bundle care, the rate
of CLABSIs in our ICUs decreased from 7.40 per 1000
central-catheter days to 3.93 per 1000 central-catheter
days. In comparison with the CLABSI rate of ICUs in devel-
oping countries from 2004 to 2009 (6.8 per 1000 central-line
days), our incidence was much lower.24 At the time TNIS
was launched in 2007, the average CLABSI rates ranged
from 5.5 per 1000 central-catheter days and 3.5 per 1000Please cite this article in press as: Lin K-Y, et al., Central line-associate
bundle care, Journal of Microbiology, Immunology and Infection (2015central-catheter days in the ICUs of medical centers and
regional hospitals, respectively.25 Our surveillance data
were higher than the benchmarking data from NHSN hos-
pitals in 2012, which was 1.3 per 1000 central-catheter days
at the medical ICUs of major teaching hospitals. The inci-
dence of CLABSIs in hospitals reporting to NHSN also varied
with the type of hospital unit, which ranged from 0.8 per
1000 central-catheter days in surgical ICUs to 3.4 per 1000
central-catheter days in burn ICUs.26 Hence, total elimi-
nation of CLABSIs may be a realistic goal for some units, but
local differences must be addressed.
Our study adds information that could improve current
prevention strategies and reduce CLABSI by addressing the
changing etiology and clinical characteristics. The causa-
tive pathogens of CLABSIs in our ICU were predominantly
Gram-negative bacteria, followed by Gram-positive bacte-
ria and Candida spp. As there were no nosocomial out-
breaks detected in our ICUs during the study period, the
epidemiological trends in this study were considered
consistent with recent studies and the serial surveillance
report of TNIS,25 however, these findings were different
from the NHSN report and older studies, wherein Gram-
positive bacteria were the predominant pathogens in cen-
tral line-related bloodstream infections. The pathogen-
specific incidence-density rates in 2010 according to NHSN
surveillance data for Enterococcus spp., Staphylococcus
aureus, Gram-negative rods, and Candida spp. were 0.28
CLABSIs per 1,000 central-catheter days, 0.14 CLABSIs per
1,000 central-catheter days, 0.26 CLABSIs per 1,000
central-catheter days, and 0.25 CLABSIs per 1,000 central-
catheter days, respectively.18,27,28 Accordingly, current
guidelines of intravascular catheter-related infection by
the Infectious Disease Society of America (IDSA) recom-
mend routine empirical coverage for Gram-positive bacte-
ria and only selective additional coverage for Gram-
negative bacteria in neutropenic or severely ill patients,
patients colonized with Gram-negative bacteria, or those
who have a femoral catheter.22
After implementation of bundle care, change in the
types of pathogens frequently isolated from central line-
related bloodstream infections has been observed in
several recent studies.12,13 These studies recorded a sig-
nificant reduction in CRBSI incidence caused by Gram-
positive bacteria and an increasing trend of CRBSI caused
by Gram-negative bacteria and fungi. Possible explanations
for the increase of Gram-negative bacteria and fungi
include the increasing complexity of the patient population
and the implementation of infection control currently tar-
geting Gram-positive organisms.12,13
There is considerable overlap between the definitions of
CLABSI and CRBSI and we assume that diagnosis of CLABSI
often overestimates the true number of infections that are
attributable to central lines. Therefore, we compared the
microbiological characteristics of CLABSI and CRBSI in this
study. In both CLABSIs and CRBSIs, the predominant caus-
ative pathogens were Gram-negative bacteria. Patients
with CRBSIs had fewer jugular catheter placements, longer
ICU stay and interval from catheter insertion to onset of
CLABSI, and more fungal and mixed pathogen infections.
The mixed pathogens comprised mostly Candida spp. and
NFGNB. A possible explanation for the fact that more fungi
and mixed pathogens were identified in CRBSIs was thatd bloodstream infections among critically-ill patients in the era of
), http://dx.doi.org/10.1016/j.jmii.2015.07.001
Table 3 Factors associated with 14-day mortality in patients with CLABSIs
Variable Univariate analysis Multivariate analysis
Survival (n Z 111) Mortality (n Z 70) p p OR (95% CI)
Age (y) 66.5  16.6 65.6  14.7 0.570 e e
Male 68 (61.3) 45 (64.3) 0.682 e e
Underlying disease
Cardiovascular disease 40 (36.0) 31 (44.3) 0.268 e e
Neurological disease 35 (31.5) 13 (18.6) 0.054 0.063 e
Respiratory disease 19 (17.1) 9 (12.9) 0.440 e e
Gastrointestinal disease 14 (12.6) 11 (15.7) 0.556 e e
Hepatobiliary disease 23 (20.7) 15 (21.4) 0.909 e e
Renal disease 35 (31.5) 24 (34.3) 0.700 e e
Autoimmune disease 4 (3.6) 8 (11.4) 0.039 0.633 e
Diabetes mellitus 43 (38.7) 21 (30.0) 0.231 e e
Malignancy 46 (41.4) 31 (44.3) 0.706 e e
Immunosuppression 5 (4.5) 5 (7.1) 0.449 e e
Charlson comorbidity index 4.4  2.8 4.9  2.9 0.277 e e
Major diagnosis on ICU admission
Cardiovascular disease 16 (14.4) 15 (21.4) 0.223 e e
Neurological disease 8 (7.2) 0 (0) 0.022 0.999 e
Respiratory disease 44 (39.6) 32 (45.7) 0.420 e e
Gastrointestinal disease 11 (9.9) 5 (7.1) 0.523 e e
Hepatobiliary disease 3 (2.7) 3 (4.3) 0.562 e e
Genitourinary 7 (6.3) 3 (4.3) 0.562 e e
Malignancy 5 (4.5) 4 (5.7) 0.715 e e
Infection 62 (55.9) 39 (55.7) 0.985 e e
Trauma 5 (4.5) 1 (1.4) 0.260 e e
APACHE II score 21.6  8.4 21.9  8.6 0.808 e e
Clinical signs
Shock 43 (38.7) 47 (67.1) <0.001 0.859 e
AKI 50 (45.1) 41 (58.6) 0.076 0.536 e
DIC 24 (21.6) 30 (42.9) 0.002 0.142 e
Pitt bacteremia score 4.2  2.6 6.5  2.8 <0.001 <0.001 1.41 (1.18e1.68)
Pathogen
Gram-positive bacteria 38 (34.2) 22 (31.4) 0.696 e e
Gram-negative bacteria 47 (42.3) 24 (34.3) 0.280 e e
Anaerobes 4 (3.6) 3 (4.3) 0.817 e e
Fungi 27 (24.3) 23 (32.9) 0.211 e e
Mixed organisms 9 (8.1) 5 (7.1) 0.813 e e
Resistant strain 28 (25.2) 19 (27.1) 0.774 e e
Number of catheters 1.5  0.5 1.7  0.7 0.066 0.283 e
Catheter lumen 2.8  0.5 2.8  0.4 0.816 e e
Anatomic site
Internal jugular vein 66 (59.5) 42 (60.0) 0.942 e e
Subclavian vein 18 (16.2) 11 (15.7) 0.929 e e
Femoral vein 28 (25.2) 18 (25.7) 0.941 e e
Place of line insertion
ICU 64 (57.7) 53 (75.7) 0.013 0.577 e
Treatment
Adequate antibiotics 94 (84.7) 53 (75.7) 0.132 0.544 e
Combination of antibiotics 5 (4.5) 3 (4.3) 0.944 e e
Catheter removal 97 (87.4) 50 (71.4) 0.007 0.999 e
Eradication of bacteremia 75 (67.6) 33 (47.1) 0.006 0.452 e
Interval from onset of CLABSI to
adequate antibiotics (d)
2 (0e8) 1 (0e8) 0.870 e e
Interval from onset of CLABSI to
catheter removal (d)
1 (0e22) 2 (0e33) 0.051 0.021 1.10 (1.02e1.20)
Data are presented as n (%), mean  SD, or median (range).
AKI Z acute kidney injury; CI Z confidence interval; CLABSI Z central line-associated bloodstream infection; DIC Z disseminated
intravascular coagulopathy; ICU Z intensive care unit; OR Z odds ratio.
Central lineeassociated bloodstream infections 7
+ MODEL
Please cite this article in press as: Lin K-Y, et al., Central line-associated bloodstream infections among critically-ill patients in the era of
bundle care, Journal of Microbiology, Immunology and Infection (2015), http://dx.doi.org/10.1016/j.jmii.2015.07.001
8 K.-Y. Lin et al.
+ MODELthose pathogens prompted catheter removal according to
IDSA guidelines and positive semiquantitative tip culture
constituted the definition of CRBSI.22 In previous studies,
the specific patient population at risk for Gram-negative
CRBSIs included patients with spinal cord injuries, femoral
catheters, hematologic malignancy, gastrointestinal colo-
nization, or prolonged stay in the ICU, whereas fungal CRBSI
was associated with femoral catheters or administration of
parenteral nutrition.12,13,29,30 Given the fact that most
patients in our study population had a malignancy as their
underlying disease (42.5%) and had been exposed to many
antibiotics (3), it is not surprising that Gram-negative bac-
teria caused 39.2% of CLABSIs in our ICUs. This epidemio-
logical shift prompts the development of prevention
strategies directed against Gram-negative bacteria,
including empiric coverage.29 In CLABSI associated with
Gram-negative bacteria in our study, NFGNB were the most
common pathogens. These pathogens are ubiquitously
distributed in diverse environmental sources and are asso-
ciated with central line placement, previous antibiotics,
and steroid use.31,32 The remaining causative Gram-
negative bacteria, Enterobacteriaceae spp., were over-
represented in patients with neutropenia following
chemotherapy.
The strategies for decreasing CLABSIs associated with
Gram-negative bacteria should focus on both protecting
patients from the exogenous organisms and controlling
endogenous sources.33 Most present infection-control
methods for preventing CLABSI, including contact isola-
tion, skin disinfection, and hand hygiene, are focused on
exogenous organisms, especially for Gram-positive skin
flora. Studies showed that decolonization of endogenous
organisms by selective oropharyngeal or digestive decon-
tamination has benefits in preventing bloodstream in-
fections associated with Gram-negative bacteria.34,35 NHSN
recently released revised CLABSI definitions that included a
category of mucosal-barrier injury with laboratory-
confirmed bloodstream infection to reduce the number of
cases due to bacterial translocation in immunocompro-
mised patients.36,37 Implementation of these definitions
and developments to reduce CLABSI caused by Gram-
negative bacteria need further study.
Several studies have addressed CRBSI risk factors and
prognosis in different clinical settings and populations, but
the data specifically for critically-ill patients with CLABSIs
are scarce.38,39 In our analysis, there was no difference in
mortality between patients with CLABSI and patients with
CRBSI, and the severity of bacteremia and delay in catheter
removal were the only two independent factors related to
14-day mortality in the CLABSI group. In previous CRBSI
studies, two protective factors had been identified: cath-
eter removal and appropriate antimicrobial therapy.39 Our
findings with regard to CLABSI are similar. Hence, CLABSI
and CRBSI may be regarded as equivalent in studies to
identify prognostic factors. In our study, the percentage of
adequate empirical antibiotics was very high (84.7% in the
CLABSI group and 75.7% in the CRBSI group). Thus, disease
severity may be the major independent factor associated
with mortality. Delayed catheter removal rather than the
act of catheter removal was the other independent factor
associated with mortality, highlighting the importance of
timeliness.39,40Please cite this article in press as: Lin K-Y, et al., Central line-associate
bundle care, Journal of Microbiology, Immunology and Infection (2015This study had several limitations and the results should
be interpreted with caution. First, although our investiga-
tion was conducted prospectively over a period of 18
months using CLABSI data from a large medical center, our
sample size was still limited to a single medical center.
Second, the compliance rate of our interventional bundle
and checklist was nearly 95%, so our findings may not be
comparable to those in institutions whose compliance rates
are substantially different from ours. Third, the definition
of CLABSI had been changed since 2011, therefore, the
comparison of incidence and microbiological distribution
before and after implementation of bundle care should
take note of these secular changes. Despite these limita-
tions, we provide valuable information on the incidence
and etiology of CLABSI and factors associated with mor-
tality in CLABSIs in critically-ill Asian patients.
In conclusion, the increasing trend of CLABSI caused by
Gram-negative bacteria and fungi after implementation of
bundle care should not be ignored. In institutions with
CLABSI caused predominantly by Gram-negative bacteria,
additional infection-control measures to control endoge-
nous flora spreading and empiric antibiotic for CLABSI are
essential. The mortality of CLABSI was associated with the
severity of bacteremia and delayed catheter removal.
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